High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules.
about
High molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapyHeat shock protein vaccines against glioblastoma: from bench to bedsidePathways of antigen processing.Fusion of Hsp70 to Mage-a1 enhances the potency of vaccine-specific immune responsesHSPs drive dichotomous T-cell immune responses via DNA methylome remodelling in antigen presenting cells.Gp96 SIV Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosaRegulation of the expression of chaperone gp96 in macrophages and dendritic cells.Specific deletion of LDL receptor-related protein on macrophages has skewed in vivo effects on cytokine production by invariant natural killer T cells.Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to comeInteraction of Toll-Like Receptors with the Molecular Chaperone Gp96 Is Essential for Its Activation of Cytotoxic T Lymphocyte Response.Identification of the cellular sentinels for native immunogenic heat shock proteins in vivo.Establishment of tumor-associated immunity requires interaction of heat shock proteins with CD91.Heat-shock proteins as dendritic cell-targeting vaccines--getting warmer.Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequenciesThe LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular DiseaseA role for the heat shock protein-CD91 axis in the initiation of immune responses to tumors.CD91-Dependent Modulation of Immune Responses by Heat Shock Proteins: A Role in Autoimmunity.
P2860
Q26853566-7C1E658B-ED02-40E4-83D1-2BBC14262CB7Q28087775-D6AAD491-08D7-4436-A957-FC654218CB7DQ33631854-4F0594A4-5873-4A38-A38F-D826F6ABA757Q33643966-F8ED9B22-18AD-4D9E-92DC-A77A59855D14Q33766735-9D50EAD2-7745-4E4F-81CD-2E4846B9B0F1Q34727695-D8DF5CD0-EB8C-4B20-90EF-BEAB621317CCQ35022721-BFC619AF-0164-4A20-AF9E-FED836EB7086Q35210966-F56174C0-0D50-41C1-AD34-E0FC0D2A7509Q35624884-74580829-D360-4575-AE00-D2D22CF94C8CQ36018660-CB1EA9CB-DC92-41E9-BA43-13EF8B27C1A7Q37240798-79B05C50-6C93-4C39-A17C-CB2F90B372A1Q37732973-144B62AD-7ACF-4635-A82B-EDE41ABBA27AQ38095583-BEB8BA02-616B-451D-A73A-313F4DB07AF6Q39156328-5E4ADE1D-9D22-4701-946E-98B3F9D0972AQ42011629-827490CC-1D9C-4429-BDA9-9DC217C682E8Q42056136-9809A7AB-958D-42B3-9164-29604305B436Q42283936-01D58647-ABCC-4F68-864C-AB40122B106C
P2860
High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High efficiency CD91- and LOX- ...... peptides by MHC II molecules.
@ast
High efficiency CD91- and LOX- ...... peptides by MHC II molecules.
@en
High efficiency CD91- and LOX- ...... peptides by MHC II molecules.
@nl
type
label
High efficiency CD91- and LOX- ...... peptides by MHC II molecules.
@ast
High efficiency CD91- and LOX- ...... peptides by MHC II molecules.
@en
High efficiency CD91- and LOX- ...... peptides by MHC II molecules.
@nl
prefLabel
High efficiency CD91- and LOX- ...... peptides by MHC II molecules.
@ast
High efficiency CD91- and LOX- ...... peptides by MHC II molecules.
@en
High efficiency CD91- and LOX- ...... peptides by MHC II molecules.
@nl
P2093
P2860
P1433
P1476
High efficiency CD91- and LOX- ...... peptides by MHC II molecules.
@en
P2093
Pramod K Srivastava
Tatsuya Sawamura
Toyoshi Matsutake
P2860
P577
2010-08-02T00:00:00Z